I first became interested in drugs to treat brain diseases with I was a pharmacy student at Northeastern in the early 1980s. After I got my PhD in medicinal chemistry at the University of California–San Francisco, I returned to Boston for a post-doctoral fellowship at Harvard Medical School. At the time, I was drawn to research on neurodegenerative diseases, such as Parkinson’s. But by 1987, I switched to neuropsychiatric diseases, and that’s what I’ve been focused on ever since.
Imagine having the ability to take a single pill, or have one injection, and be ready for an MRI, CT scan, and PET scan at the same time?
In recent years, a body of publications in the microbiology field has challenged all previous knowledge of how antibiotics kill bacteria.